Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. HSCS
HSCS logo

HSCS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

HSCS News

HeartSciences Partners with Cibolo Health for ECG Management

Jan 29 2026Newsfilter

HeartSciences Submits MyoVista Device to FDA, Advancing AI ECG Technology

Dec 15 2025Globenewswire

HeartSciences Submits MyoVista Device for FDA 510(k) Clearance

Dec 15 2025Newsfilter

Ascendiant Capital Reaffirms Buy Rating on HeartSciences, Reduces Price Target to $9

Oct 01 2025Benzinga

HeartSciences Shares Business Update and Announces Financial Results for First Quarter of Fiscal 2026

Sep 11 2025Newsfilter

Join the Live Stream of Day 1 at the Emerging Growth Conference 85 on August 20; Registration Now Open

Aug 18 2025Globenewswire

HeartSciences Announces Conference Participation and Investor Webinar

Aug 15 2025Newsfilter

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Jun 04 2025Newsfilter

HeartSciences: FDA Grants Breakthrough Device Designation For Aortic Stenosis ECG Algorithm

Jun 04 2025NASDAQ.COM

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

Jun 03 2025Newsfilter

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

May 29 2025Newsfilter

Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream

May 19 2025Globenewswire

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

May 08 2025Newsfilter

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Mar 13 2025Globenewswire

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

Mar 10 2025Newsfilter

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Dec 16 2024Newsfilter